Association Between Daily Worry, Pathological Worry, and Fear of Progression in Patients With Cancer

被引:12
作者
Dinkel, Andreas [1 ]
Marten-Mittag, Birgitt [1 ]
Kremsreiter, Katrin [1 ,2 ]
机构
[1] Tech Univ Munich, Sch Med, Dept Psychosomat Med & Psychotherapy, Klinikum Rechts Isar, Munich, Germany
[2] Univ Med Ctr Mannheim, Inst Psychiat & Psychosomat Psychotherapy, Cent Inst Mental Hlth Mannheim, Mannheim, Germany
关键词
anxiety; cancer; distress; fear of progression; fear of recurrence; psycho-oncology; worry; DYSFUNCTIONAL FEAR; CLINICAL FEAR; GROUP-THERAPY; RECURRENCE; VALIDATION; ANXIETY; QUESTIONNAIRE; VALIDITY; FEATURES;
D O I
10.3389/fpsyg.2021.648623
中图分类号
B84 [心理学];
学科分类号
04 ; 0402 ;
摘要
Background: Fear of progression (FoP), or fear of cancer recurrence (FCR), is characterized by worries or concerns about negative illness-related future events. Actually, to worry is a common cognitive process that, in its non-pathological form, belongs to daily life. However, worry can also become pathological appearing as a symptom of mental disorders. This study aimed at investigating the associations among daily worry, pathological worry, and FoP in patients with cancer. Methods: This is a cross-sectional study that includes 328 hospitalized patients with cancer. Patients filled out the FoP Questionnaire (FoP-Q), the Worry Domains Questionnaire (WDQ) for the assessment of daily worry, and the Penn State Worry Questionnaire (PSWQ) for the assessment of pathological worry. Depressive, anxiety, and somatic symptoms were measured with modules of the Patient Health Questionnaire [Patient Health Questionnaire-Depressive Symptoms (PHQ-2), Generalized Anxiety Disorder-2 (GAD-2), and Patient Health Questionnaire-Somatic Symptoms (PHQ-15)]. Furthermore, a structured clinical interview was conducted for the assessment of anxiety disorders. The hierarchical multiple linear regression analysis was used to identify factors independently associated with FoP. Results: Mean age of the participants was M = 58.5 years (SD = 12.8), and 64.6% were men. FoP and worry were significantly intercorrelated (r = 0.58-0.78). The level of FoP was most strongly associated with daily worry (beta = 0.514, p < 0.001), followed by pathological worry (beta = 0.221, p < 0.001). Further significant determinants were younger age and depressive and anxiety symptoms. Clinical variables were not independently associated with FoP. The final model explained 74% of the variance. Discussion: Fear of progression is strongly associated with daily worry and pathological worry. These results bring up the question of whether FoP is an expression of a general tendency to worry. Whether a general tendency to worry, in fact, represents an independent vulnerability factor for experiencing FCR/FoP needs to be investigated in a longitudinal research design.
引用
收藏
页数:9
相关论文
共 47 条
[1]   Fear of Progression in Chronic Diseases [J].
Berg, Petra ;
Book, Katrin ;
Dinkel, Andreas ;
Henrich, Gerhard ;
Marten-Mittag, Birgitt ;
Mertens, Dennis ;
Ossner, Christine ;
Volmer, Sandra ;
Herschbach, Peter .
PSYCHOTHERAPIE PSYCHOSOMATIK MEDIZINISCHE PSYCHOLOGIE, 2011, 61 (01) :32-37
[2]   Could worry and rumination mediate relationships between self-compassion and psychological distress in breast cancer survivors? [J].
Brown, Stephen L. ;
Hughes, Maria ;
Campbell, Sophie ;
Cherry, M. Gemma .
CLINICAL PSYCHOLOGY & PSYCHOTHERAPY, 2020, 27 (01) :1-10
[3]   Factors reported to influence fear of recurrence in cancer patients: a systematic review [J].
Crist, Jade V. ;
Grunfeld, Elizabeth A. .
PSYCHO-ONCOLOGY, 2013, 22 (05) :978-986
[4]   Testing a model of fear of cancer recurrence or progression: the central role of intrusions, death anxiety and threat appraisal [J].
Curran, L. ;
Sharpe, L. ;
MacCann, C. ;
Butow, P. .
JOURNAL OF BEHAVIORAL MEDICINE, 2020, 43 (02) :225-236
[5]   Anxiety in the context of cancer: A systematic review and development of an integrated model [J].
Curran, Leah ;
Sharpe, Louise ;
Butow, Phyllis .
CLINICAL PSYCHOLOGY REVIEW, 2017, 56 :40-54
[6]   The Cancer Worry Scale Detecting Fear of Recurrence in Breast Cancer Survivors [J].
Custers, Jose A. E. ;
van den Berg, Sanne W. ;
van Laarhoven, Hanneke W. M. ;
Bleiker, Eveline M. A. ;
Gielissen, Marieke F. M. ;
Prins, Judith B. .
CANCER NURSING, 2014, 37 (01) :E44-E50
[7]  
Dinkel Andreas, 2018, Recent Results Cancer Res, V210, P13, DOI 10.1007/978-3-319-64310-6_2
[8]   Comorbidity of fear of progression and anxiety disorders in cancer patients [J].
Dinkel, Andreas ;
Kremsreiter, Katrin ;
Marten-Mittag, Birgitt ;
Lahmann, Claas .
GENERAL HOSPITAL PSYCHIATRY, 2014, 36 (06) :613-619
[9]   Determinants of Long-term Response to Group Therapy for Dysfunctional Fear of Progression in Chronic Diseases [J].
Dinkel, Andreas ;
Herschbach, Peter ;
Berg, Petra ;
Waadt, Sabine ;
Duran, Gabriele ;
Engst-Hastreiter, Ursula ;
Henrich, Gerhard ;
Book, Katrin .
BEHAVIORAL MEDICINE, 2012, 38 (01) :1-5
[10]   Fear of cancer recurrence: a theoretical review and novel cognitive processing formulation [J].
Fardell, Joanna E. ;
Thewes, Belinda ;
Turner, Jane ;
Gilchrist, Jemma ;
Sharpe, Louise ;
Smith, Allan 'Ben' ;
Girgis, Afaf ;
Butow, Phyllis .
JOURNAL OF CANCER SURVIVORSHIP, 2016, 10 (04) :663-673